We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$54.9B
AUM Growth
-$1.43B
Cap. Flow
-$10.1B
Cap. Flow %
-18.32%
Top 10 Hldgs %
15.84%
Holding
4,613
New
106
Increased
2,539
Reduced
1,420
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Financials 5.47%
3 Healthcare 4.96%
4 Consumer Discretionary 4.64%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KA
4126
DELISTED
Kineta, Inc. Common Stock
KA
$483 ﹤0.01%
2
-26
-93% -$5.84K
CTLP
4127
DELISTED
Cantaloupe
CTLP
$481 ﹤0.01%
65
AINC
4128
DELISTED
Ashford Inc.
AINC
$472 ﹤0.01%
20
-102
-84% -$2.43K
BN icon
4129
Brookfield
BN
$109B
$462 ﹤0.01%
22
-421
-95% -$8.39K
MNTX
4130
DELISTED
Manitex International, Inc.
MNTX
$458 ﹤0.01%
77
-1,602
-95% -$9.13K
ZLAB icon
4131
Zai Lab
ZLAB
$2.86B
$457 ﹤0.01%
11
KODK icon
4132
Kodak
KODK
$968M
$446 ﹤0.01%
96
-3,031
-97% -$8.39K
CRVS icon
4133
Corvus Pharmaceuticals
CRVS
$1.28B
$430 ﹤0.01%
79
-1,727
-96% -$6.04K
CTIC
4134
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$430 ﹤0.01%
272
-5,827
-96% -$5.52K
GYRE icon
4135
Gyre Therapeutics
GYRE
$722M
$429 ﹤0.01%
8
-181
-96% -$7.58K
ORN icon
4136
Orion Group Holdings
ORN
$400M
$426 ﹤0.01%
82
-3,097
-97% -$15.4K
VSTM icon
4137
Verastem
VSTM
$633M
$414 ﹤0.01%
26
-616
-96% -$8.86K
NYMX
4138
DELISTED
Nymox Pharmaceutical Corp
NYMX
$407 ﹤0.01%
185
-3,470
-95% -$6.85K
KINS icon
4139
Kingstone Companies
KINS
$281M
$403 ﹤0.01%
52
-1,020
-95% -$8.1K
FENC icon
4140
Fennec Pharmaceuticals
FENC
$423M
$402 ﹤0.01%
62
-1,354
-96% -$7.27K
SREV
4141
DELISTED
ServiceSource International, Inc.
SREV
$401 ﹤0.01%
240
-8,660
-97% -$11.3K
AMPE
4142
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$400 ﹤0.01%
2
-39
-95% -$5.04K
CVE icon
4143
Cenovus Energy
CVE
$55.6B
$396 ﹤0.01%
39
NEOS
4144
DELISTED
Neos Therapeutics, Inc
NEOS
$393 ﹤0.01%
260
-5,264
-95% -$7.9K
KG
4145
Kestrel Group
KG
$69.2M
$390 ﹤0.01%
26
-572
-96% -$7.67K
TRAK icon
4146
ReposiTrak
TRAK
$154M
$380 ﹤0.01%
75
-1,444
-95% -$7.42K
ISEE
4147
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$352 ﹤0.01%
41
NIHD
4148
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$352 ﹤0.01%
162
-18,950
-99% -$36.7K
OXFD
4149
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$349 ﹤0.01%
21
-1,530
-99% -$24.8K
BSMX
4150
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$346 ﹤0.01%
51

Similar funds

BNP Paribas Financial Markets's Q4 2019 Portfolio in Review

As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.

  • BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
  • BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
  • BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
  • BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
  • BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
  • BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.